Literature DB >> 24760987

The single-biopsy approach in determining protein synthesis in human slow-turning-over tissue: use of flood-primed, continuous infusion of amino acid tracers.

Lars Holm1, Søren Reitelseder2, Kasper Dideriksen3, Rie H Nielsen3, Jacob Bülow3, Michael Kjaer3.   

Abstract

Muscle protein synthesis (MPS) rate is determined conventionally by obtaining two or more tissue biopsies during a primed, continuous infusion of a stable isotopically labeled amino acid. The purpose of the present study was to test whether tracer priming given as a flooding dose, thereby securing an instantaneous labeling of the tissue pools of free tracee amino acids, followed by a continuous infusion of the same tracer to maintain tracer isotopic steady state, could be used to determine the MPS rate over a prolonged period of time by obtaining only a single tissue biopsy. We showed that the tracer from the flood prime appeared immediately in the muscle free pool of amino acids and that this abundance could be kept constant by a subsequent continuous infusion of the tracer. When using phenylalanine as tracer, the flood-primed, continuous infusion protocol does not stimulate the MPS rate per se. In conclusion, the flood-primed, continuous infusion protocol using phenylalanine as tracer can validly be used to measure the protein synthesis rate in human in vivo experiments by obtaining only a single tissue biopsy after a prolonged infusion period.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  fractional synthesis rate; protein turnover; stable isotope; tracer administration

Mesh:

Substances:

Year:  2014        PMID: 24760987     DOI: 10.1152/ajpendo.00084.2014

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  6 in total

1.  Modeling the contribution of individual proteins to mixed skeletal muscle protein synthetic rates over increasing periods of label incorporation.

Authors:  Benjamin F Miller; Christopher A Wolff; Fredrick F Peelor; Patrick D Shipman; Karyn L Hamilton
Journal:  J Appl Physiol (1985)       Date:  2015-01-15

2.  Even effect of milk protein and carbohydrate intake but no further effect of heavy resistance exercise on myofibrillar protein synthesis in older men.

Authors:  Søren Reitelseder; Kasper Dideriksen; Jakob Agergaard; Nikolaj M Malmgaard-Clausen; Rasmus L Bechshoeft; Rasmus K Petersen; Anja Serena; Ulla R Mikkelsen; Lars Holm
Journal:  Eur J Nutr       Date:  2018-02-22       Impact factor: 5.614

3.  Beta2 -adrenoceptor agonist salbutamol increases protein turnover rates and alters signalling in skeletal muscle after resistance exercise in young men.

Authors:  Morten Hostrup; Søren Reitelseder; Søren Jessen; Anders Kalsen; Michael Nyberg; Jon Egelund; Michael Kreiberg; Caroline Maag Kristensen; Martin Thomassen; Henriette Pilegaard; Vibeke Backer; Glenn A Jacobson; Lars Holm; Jens Bangsbo
Journal:  J Physiol       Date:  2018-07-30       Impact factor: 5.182

4.  Muscle protein breakdown is impaired during immobilization compared to during a subsequent retraining period in older men: no effect of anti-inflammatory medication.

Authors:  K Dideriksen; S Reitelseder; J Agergaard; A P Boesen; S N Aas; T Raastad; Lars Holm
Journal:  Pflugers Arch       Date:  2020-02-05       Impact factor: 3.657

5.  Human Muscle Protein Synthesis Rates after Intake of Hydrolyzed Porcine-Derived and Cows' Milk Whey Proteins-A Randomized Controlled Trial.

Authors:  Line Q Bendtsen; Tanja K Thorning; Søren Reitelseder; Christian Ritz; Erik T Hansen; Gerrit van Hall; Arne Astrup; Anders Sjödin; Lars Holm
Journal:  Nutrients       Date:  2019-04-30       Impact factor: 5.717

6.  An exploration of the methods to determine the protein-specific synthesis and breakdown rates in vivo in humans.

Authors:  Lars Holm; Kasper Dideriksen; Rie H Nielsen; Simon Doessing; Rasmus L Bechshoeft; Grith Højfeldt; Marcus Moberg; Eva Blomstrand; Søren Reitelseder; Gerrit van Hall
Journal:  Physiol Rep       Date:  2019-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.